Trial intelligence / Profile preview

Association Between TDV Exposure and Dengue Hospitalization in Thai Children

TCTR20250421002Not yet recruiting

Sponsor
Takeda
Start
Mar 2025
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Trial of dengue tetravalent vaccine, live, attenuated in dengue fever (4 arms), sponsored by Takeda. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

dengue tetravalent vaccine, live, attenuated
03

Conditions

dengue fever

Beyond the preview

Go deeper on TCTR20250421002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250421002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call